Panoptes Pharma GmbH
🇦🇹Austria
- Country
- 🇦🇹Austria
- Ownership
- Subsidiary
- Established
- 2013-01-01
- Employees
- 1
- Market Cap
- -
Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)A Phase I Study of PP-001 Eye Drops in Healthy Adult Volunteers
Phase 1
Completed
- Conditions
- KeratoconjunctivitisOcular Surface Disease
- Interventions
- Other: Placebo
- First Posted Date
- 2018-12-07
- Last Posted Date
- 2024-01-12
- Lead Sponsor
- Panoptes Pharma GmbH
- Target Recruit Count
- 45
- Registration Number
- NCT03769454
- Locations
- 🇦🇹
University Hospital Vienna, Vienna, Austria
A Safety Study of Intravitreal PP-001 in Patients With Chronic, Non-Infectious Uveitis
- First Posted Date
- 2018-08-16
- Last Posted Date
- 2024-10-09
- Lead Sponsor
- Panoptes Pharma GmbH
- Target Recruit Count
- 12
- Registration Number
- NCT03634475
- Locations
- 🇦🇹
University Hospital Vienna, Vienna, Austria
🇧🇪University Hospital Leuven, Leuven, Belgium
🇩🇪Charité Berlin, Berlin, Germany
News
No news found